CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
70 hedge funds and large institutions have $19.8M invested in Carisma Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.16% more ownership
Funds ownership: 0.64% → 0.8% (+0.16%)
67% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 24
Holders
70
Holding in Top 10
1
Calls
$1.14M
Puts
$1.09M
Top Buyers
| 1 | +$244K | |
| 2 | +$150K | |
| 3 | +$143K | |
| 4 |
E
Ergoteles
New York
|
+$54.7K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
+$50.2K |
Top Sellers
| 1 | -$831K | |
| 2 | -$106K | |
| 3 | -$94.3K | |
| 4 |
Morgan Stanley
New York
|
-$83.7K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$80K |